Prevalence of Sexually Transmitted Infections (STIs) and Coinfections in the General Population

Not yet recruiting

• Conditions: HIV Infections
• Interventions: Diagnostic Test: Blood sample

• Registration Number: NCT05983679
• Lead Sponsor: CerbaXpert

Brief Summary

Prevalence of Sexually Transmitted Infections (STIs) and co-infections in the general population

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-06-22
• Study First Submitted QC: 2023-08-07
• Study First Posted: 2023-08-09
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-12
• Last Update Posted: 2024-04-15
• Study Start: 2024-12-04
• Primary Completion: 2025-09-04
• Study Completion: 2026-09-04

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 9000

Inclusion Criteria

• Subject, male or female, 18 years of age or older
• Subject capable of understanding the purpose of the research having given their free and informed written consent
• Subject presenting to the laboratory for a biological examination
• Affiliated subject or beneficiary of a social security scheme

Exclusion Criteria

• Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Adults	Blood sample	-

Primary Outcome Measures

Name	Time	Method
The prevalence of each STI will be assessed by the participant's positive or negative status for each pathogen, determined by the following screening tests:	3 years	HIV testing is based on finding antibodies to HIV-1 and HIV-2 and P24 antigen of the virus; * Hepatitis B screening is based on HBsAg (hepatitis B surface antigen) research; * Herpes screening is based on testing for antibodies to Herpes Simplex virus (HSV-1 and HSV-2); * Papilloma virus screening is based on the HPV-HR test from a smear on the cervix; * Chlamydia screening is based on a nucleic acid amplification (NAAT) test; * Gonorrhea screening is based on the identification of the bacteria on a urine sample or secretions from the vagina or cervix; * Screening for trichomoniasis is based on a molecular diagnosis that involves identifying the parasite's DNA from a genital or urinary sample; * The detection of syphilis is based on antibody research.